genome analysis
Sophia Genetics to Commercialize MSK-ACCESS Clinical Liquid Biopsy Test
The collaboration between Sophia and Memorial Sloan Kettering Cancer Center aims to offer new testing and analytics capabilities to clinicians and researchers.
Variantyx Secures $20M Debt Financing to Support Precision Medicine in North America, Europe
The maker of diagnostic WGS analysis software looks to grow its market share after expanding into oncology and prenatal testing last year.
P4 Diagnostix, Pierian Partner to Offer Somatic Prostate Cancer Testing
The companies will use Illumina's TruSight Oncology 500 cancer panel to complement P4's UroSeq NGS-based germline testing.
Sophia Genetics Partners With MSK on Clinical Decision Support, Boundless Bio on ecDNA Detection
Sophia will provide Memorial Sloan Kettering with predictive tumor analysis technology and help startup Boundless develop new therapies and MDx methods.
Congenica Partners With Indian Diagnostics Lab for Genomic Analysis, Reporting
The partnership with Avesthagen subsidiary Avgen Diagnostics seeks to improve sequencing-based diagnostics services in India with rapid NGS analysis.
May 11, 2022
Mar 25, 2022
Nalagenetics Closes $12.6M Series A Funding Round
Jan 20, 2022
Nov 10, 2021
Geneyx Genomex Closes $6.5M Seed Financing Round
Nov 10, 2021
Sophia Genetics Q3 Revenues Increase 44 Percent
Sep 9, 2021
Sophia Genetics Q2 Revenue Grows 72 Percent
Jul 19, 2021
Sophia Genetics Increases IPO Target to $221M
May 6, 2021
NantHealth Q1 Revenues Decline 11 Percent
Feb 25, 2021
NantHealth Q4 Revenues Flat From Year Ago
Nov 5, 2020